Does Prediabetes Go Away? Reversal Explained

Prediabetes, known in the UK as non-diabetic hyperglycaemia (NDH), does not have to be a one-way road to type 2 diabetes. Whether prediabetes goes away depends on several factors, including lifestyle changes, body weight, and how consistently healthy habits are maintained. Many people do return to normal blood glucose levels with the right support, while others stabilise without progressing further. This article explains what the evidence says about reversing NDH, which lifestyle changes make the biggest difference, how long improvement takes, when medication may be needed, and what the risks are if the condition is left untreated.

Can prediabetes be reversed, or does it always lead to type 2 diabetes?

Prediabetes can be reversed in many people and does not inevitably progress to type 2 diabetes. Structured lifestyle intervention through programmes such as the NHS DPP can significantly reduce progression risk, though reversal is not guaranteed and regular monitoring remains essential.

Prediabetes can be reversed in many people, and it does not inevitably progress to type 2 diabetes. In the UK, the condition is more commonly referred to as non-diabetic hyperglycaemia (NDH). It is identified through blood glucose levels that are higher than normal but not yet high enough to meet the diagnostic threshold for type 2 diabetes.

In UK practice, NDH is typically identified through an HbA1c reading of 42 to 47 mmol/mol.^[1][2] The fasting plasma glucose (FPG) range used for case-finding varies by setting: NHS Diabetes Prevention Programme (NHS DPP) case-finding commonly uses an FPG of 5.5 to 6.9 mmol/l, while some clinical definitions use 6.1 to 6.9 mmol/l. The appropriate threshold in any individual case depends on the test used and local referral criteria; your GP or practice nurse can advise which applies to your result.

Research underpinning the NHS DPP (Healthier You) shows that structured lifestyle intervention can significantly reduce the risk of progression to type 2 diabetes. Some individuals return to normal blood glucose ranges entirely, while others stabilise at NDH levels without progressing further. The outcome depends on a range of factors, including the degree of insulin resistance, body weight, age, family history, and how consistently lifestyle changes are maintained.

Reversal is not guaranteed, and NDH can recur if healthy habits are not sustained. Regular monitoring remains essential even after blood glucose levels improve. NICE prevention guidance for people at high risk of type 2 diabetes (formerly PH38, now incorporated into updated NICE guidance) recommends that adults identified with NDH are offered referral to an intensive lifestyle change programme and have their HbA1c or fasting glucose checked at least annually.^[1][2] Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, which may be relevant for people managing weight as part of their NDH care.

What lifestyle changes give you the best chance of reversing prediabetes?

Sustained weight loss of 5 to 10 per cent of body weight, at least 150 minutes of moderate aerobic activity per week, and a diet lower in refined carbohydrates and higher in fibre offer the strongest evidence for reversing NDH.

The lifestyle changes with the strongest evidence for reversing NDH are a sustained reduction in body weight, increased physical activity, and improvements to dietary quality. NICE prevention guidance for people at high risk of type 2 diabetes and the NHS DPP both indicate that even a modest weight loss of 5 to 10 per cent of body weight can meaningfully improve insulin sensitivity and lower blood glucose levels in people with NDH.^[1][2]

In terms of diet, the evidence supports reducing overall calorie intake, limiting refined carbohydrates and added sugars, increasing dietary fibre through vegetables, pulses and wholegrains, and reducing saturated fat. There is no single prescribed eating pattern, and approaches such as a Mediterranean-style diet or a lower-carbohydrate diet have both shown benefit in clinical studies. The key is finding a sustainable pattern that can be maintained long term rather than a short-term restrictive approach. Diabetes UK and the British Dietetic Association provide patient-facing dietary guidance that is consistent with NHS practice.

Physical activity plays an independent role beyond its effect on weight. The UK Chief Medical Officers' Physical Activity Guidelines recommend at least 150 minutes of moderate-intensity aerobic activity per week, such as brisk walking, cycling or swimming, alongside muscle-strengthening activities on two or more days per week. Both aerobic and resistance exercise improve glucose uptake by muscles and reduce insulin resistance.^[17][18]

Smoking cessation and reducing alcohol intake are also relevant, as both can affect insulin sensitivity and cardiovascular risk, which is already elevated in people with NDH.

The NHS DPP (Healthier You) offers a free, evidence-based programme for eligible adults in England. Equivalent structured prevention programmes are available in Scotland (through Diabetes Scotland), Wales (Diabetes Prevention Programme Wales) and Northern Ireland; referral pathways vary by nation, so ask your GP or practice nurse about local provision. Referral is typically made following a blood test result in the NDH range.

How long does it take to see your blood sugar levels improve?

Fasting glucose can begin to improve within four to eight weeks of consistent lifestyle changes, while a measurable reduction in HbA1c is typically seen after three months of sustained effort.

Blood glucose levels can begin to improve within a few weeks of making consistent lifestyle changes, though the timeline varies considerably between individuals. Early improvements in fasting glucose are often seen within four to eight weeks of dietary changes and increased physical activity, particularly when calorie intake is reduced and body weight begins to fall.

HbA1c, which reflects average blood glucose over approximately two to three months, takes longer to show a meaningful change.^[4][5] Most clinicians would expect to see a measurable reduction in HbA1c after three months of sustained lifestyle change, with further improvement possible over six to twelve months. NICE prevention guidance recommends that HbA1c or fasting glucose is rechecked at least annually in people with NDH, though some GP practices will recheck sooner if significant lifestyle changes have been made.

It is worth noting that HbA1c may be less reliable in certain circumstances, for example in people with some haemoglobinopathies or anaemia. If this applies to you, your GP may prefer to monitor your glucose using a fasting plasma glucose or oral glucose tolerance test instead.

Improvement is not always linear. Plateaus are common, and blood glucose levels can fluctuate in response to illness, stress, disrupted sleep or changes in physical activity. This does not necessarily mean the intervention has failed. Keeping a record of dietary intake, activity levels and any relevant symptoms can help a GP or practice nurse identify patterns and adjust advice accordingly.

For people who achieve a return to normal blood glucose levels, ongoing monitoring remains important. Blood glucose can rise again if lifestyle changes are not maintained, and the underlying tendency towards insulin resistance does not disappear entirely. Annual review is therefore recommended even after apparent reversal, to catch any upward trend early.

When might medication be needed alongside lifestyle changes?

Metformin may be considered off-label in high-risk adults with NDH when lifestyle intervention alone has not been sufficient, following individual clinical assessment and shared decision-making with a GP.

Medication may be considered alongside lifestyle changes when blood glucose levels remain persistently elevated despite sustained effort, when the risk of progression to type 2 diabetes is assessed as high, or when other health conditions make intensive lifestyle change difficult to achieve.

In the UK, the medicine most commonly discussed in this context is metformin. It is important to note that metformin does not hold a UK marketing authorisation specifically for NDH or prediabetes; its use in this setting is off-label.^[9][10] However, NICE prevention guidance for people at high risk of type 2 diabetes indicates that metformin may be considered in certain high-risk adults with NDH where lifestyle intervention alone has not been sufficient, following shared decision-making with a clinician.^[1][2] The decision to use metformin in this context should be made on an individual basis by a GP or specialist, taking into account the person's overall risk profile, comorbidities and preferences.

Metformin works primarily by reducing glucose production in the liver and improving the body's sensitivity to insulin.^[9][3] It is generally well tolerated, though gastrointestinal side effects such as nausea, diarrhoea and abdominal discomfort are common, particularly when starting treatment. Taking metformin with food and starting at a low dose with gradual increase can help minimise these effects. Long-term use is associated with a risk of reduced vitamin B12 absorption, and renal function should be assessed before starting and monitored during treatment.^[8][9] If you experience a suspected side effect from any medicine, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

For people with NDH who also have significant obesity, a GP may consider referral for specialist weight management support. In some cases, following assessment, a prescriber may consider licensed weight-management medicines as part of a broader treatment plan. These decisions are made on an individual basis, taking into account overall cardiovascular risk, comorbidities and patient preference.

Medication in this context is intended to complement lifestyle change, not replace it. The decision to start any medicine should follow a thorough clinical assessment and a shared decision-making conversation with a GP or specialist.

What happens if prediabetes is left untreated?

Untreated NDH carries a meaningful risk of progressing to type 2 diabetes within five to ten years and is independently associated with increased cardiovascular disease risk and early microvascular changes.

Untreated NDH carries a meaningful risk of progressing to type 2 diabetes. Population studies and meta-analyses suggest that without intervention, a substantial proportion of people with NDH will develop type 2 diabetes within five to ten years, though the risk varies considerably between individuals.^[11][12] Some people remain at NDH level for many years, particularly if they make partial lifestyle improvements, while others progress more quickly.

Beyond the risk of type 2 diabetes, NDH is independently associated with an increased risk of cardiovascular disease, including heart attack and stroke. Elevated blood glucose, even below the diabetic threshold, contributes to endothelial dysfunction, inflammation and dyslipidaemia, all of which can accelerate atherosclerosis. Evidence also suggests an association between NDH and an increased risk of chronic kidney disease and certain neuropathies over time, though the strength of these associations varies across studies and should be interpreted with appropriate caution.

There is evidence that some diabetes-related changes to small blood vessels may begin during the NDH stage rather than only after a diagnosis of type 2 diabetes is made.^[19] This underlines the importance of not treating NDH as a benign or inconsequential finding.

If you have been told your blood glucose is in the NDH range and have not yet been referred to a structured programme or received follow-up, it is appropriate to contact your GP practice to discuss next steps.

If you experience symptoms that may suggest progression to type 2 diabetes, such as increased thirst, frequent urination, unexplained fatigue or blurred vision, contact your GP for a repeat blood test. These symptoms warrant prompt assessment rather than waiting for a scheduled annual review.

If you feel very unwell, are vomiting, are unable to keep fluids down, or feel confused or drowsy alongside high blood glucose symptoms, seek urgent medical attention by calling NHS 111 or, in an emergency, 999.

Scientific References

1. Type 2 diabetes: prevention in people at high risk (PH38) – Recommendations.
2. Type 2 diabetes: prevention in people at high risk (PH38).
3. Type 2 diabetes in adults: management (NG28).
4. Having your blood glucose checked (HbA1c) – Type 1 diabetes in adults (NG17).
5. Diabetes.
6. UK Chief Medical Officers' Physical Activity Guidelines.
7. Physical activity guidelines for adults aged 19 to 64.
8. Metformin and reduced vitamin B12 levels: new advice for monitoring patients at risk.
9. Metformin hydrochloride.
10. Off-label or unlicensed use of medicines: prescribers' responsibilities.
11. Prediabetes transitions to normoglycaemia or type 2 diabetes.
12. Prediction models for progression from prediabetes to diabetes: a systematic review and meta-analysis.
13. Identifying Promising Practices in Lifestyle Intervention Programs for the Prediabetes Population: A Meta-Analysis and Meta-Regression of Randomized Controlled Trials.
14. Efficacy and safety of anti-prediabetic drugs in patients with prediabetes: a Bayesian network meta-analysis.
15. Prediabetes and the Risk of Peripheral Artery Disease: A Meta-Analysis.
16. Effect of a ketogenic diet versus Mediterranean diet on glycated hemoglobin in individuals with prediabetes and type 2 diabetes mellitus: the Keto-Med randomized crossover trial.
17. Insulin Sensitization Following a Single Exercise Bout Is Uncoupled to Glycogen in Human Skeletal Muscle: A Meta-analysis of 13 Single-Center Human Studies.
18. Relationship between aerobic fitness and adipose tissue insulin resistance.
19. Microvascular disease beyond diabetes: a metabolic continuum with implications for early detection and diabetes care.
20. Intervention for Prevention of Type 2 Diabetes Mellitus Among Prediabetes: A Review of the Literature.
21. Metformin Use and Vitamin B12 Deficiency in People with Type 2 Diabetes. What Are the Risk Factors? A Mini-systematic Review.
22. Metformin-Induced Vitamin B12 Deficiency among Type 2 Diabetes Mellitus' Patients: A Systematic Review.
23. Health matters: preventing Type 2 Diabetes.

Frequently Asked Questions